Skip to main content

Table 3 Clinical data

From: Effectiveness of a Wii balance board-based system (eBaViR) for balance rehabilitation: a pilot randomized clinical trial in patients with acquired brain injury

  Before treatment After treatment Difference Significance
BBS     
   Control 45.38 ± 7.35 46.88 ± 6.15 1.50 ± 1.31 T**(p = 0.000)
   Trial 41.22 ± 10.57 45.44 ± 8.62 4.22 ± 2.33 GxT*(p = 0.011)
BBA     
   Control 11.00 ± .1.31 11.13 ± 1.13 0.12 ± 0.35 T*(p = 0.048)
   Trial 10.00 ± 2.00 10.33 ± 2.18 0.33 ± 0.50  
ART standing (cm)     
   Control 25.44 ± 9.33 25.63 ± 9.74 0.19 ± 1.56 T**(p = 0.005)
   Trial 24.13 ± 7.70 27.25 ± 10.38 3.12 ± 2.36 GxT*(p = 0.011)
ART sitting (cm)     
   Control 40.06 ± 6.87 40.13 ± 7.66 0.06 ± 6.35 NS
   Trial 34.83 ± 11.92 37.78 ± 12.34 2.94 ± 4.05  
ST paretic (n)     
   Control 6.57 ± 2.30 7.57 ± 2.44 1.00 ± 1.29 T*(p = 0.021)
   Trial 6.75+3.58 7.63 ± 4.00 0.87 ± 1.46  
ST non-paretic (n)     
   Control 8.17 ± 1.72 9.50 ± 3.39 1.33 ± 1.97 T*(p = 0.046)
   Trial 9.33 ± 2.81 10.50 ± 3.02 1.16 ± 1.83  
TST (s)     
   Control 14.82 ± 9.42 12.13 ± 4.94 -2.69 ± 6.19 NS
   Trial 15.38 ± 9.69 13.52 ± 9.60 -1.86 ± 4.67  
1MWT (m)     
   Control 31.13 ± 13.59 36.38 ± 15.39 5.25 ± 3.99 T**(p = 0.007)
   Trial 31.94 ± 12.47 42.69 ± 20.43 10.75 ± 13.78  
10MT (s)     
   Control 14.57 ± 10.95 14.07 ± 9.02 -0.50 ± 2.16 NS
   Trial 13.47 ± 8.29 13.47 ± 10.64 -0.00 ± 2.60  
TUG (s)     
   Control 24.00 ± 14.87 19.52 ± 10.91 -4.48 ± 4.98 T**(p = 0.004)
   Trial 20.99 ± 15.11 18.69 ± 13.43 -2.30 ± 2.33  
30SST (n)     
   Control 6.88 ± 3.52 8.50 ± 3.12 1.62 ± 1.68 T**(p = 0.003)
   Trial 7.56 ± 4.19 9.00 ± 4.74 1.44 ± 1.81  
  1. Numerical data of the scores of scales and tests. The results are given in terms of mean () and standard deviation (σ). The subindexes 0 and 20 represent the assessments carried out before and after the treatment, respectively. G: group effect. T: time effect. GxT: group/time effect. * p < 0.05, ** p < 0.01. n represents the number of repetitions.